Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tardive Dyskinesia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02509338
What this trial is testing

Validation of the Implantation of a New Electrode for the Treatment of Dystonia

Who this might be right for
Generalized DystoniaSegmental DystoniaTardive Dystonia
University Hospital, Montpellier 7
Not applicableUnknownNCT01804920
What this trial is testing

D-Serine Treatment For Tardive Dyskinesia

Who this might be right for
Schizophrenia and Schizoaffective DisorderTardive Dyskinesia
Herzog Hospital 16
Not applicableNot Yet RecruitingNCT07715994
What this trial is testing

A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms

Who this might be right for
Extrapyramidal SymptomsDrug-induced ParkinsonismAkathisia, Drug-Induced+1 more
Shanghai Mental Health Center 180
Post-approval studies (Phase 4)Study completedNCT03891862
What this trial is testing

Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia (TD)
Neurocrine Biosciences 135
Post-approval studies (Phase 4)WithdrawnNCT06107829
What this trial is testing

Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
Stephen Ruedrich
Testing effectiveness (Phase 2)Looking for participantsNCT07365462
What this trial is testing

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 100
Testing effectiveness (Phase 2)Looking for participantsNCT06731868
What this trial is testing

Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia (TD)
Luye Pharma Group Ltd. 120
Not applicableStudy completedNCT03287778
What this trial is testing

Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaAntipsychotic Agents
University of North Carolina, Chapel Hill 17
Large-scale testing (Phase 3)Study completedNCT00190008
What this trial is testing

Piracetam for Treatment Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Beersheva Mental Health Center 40
Large-scale testing (Phase 3)Study completedNCT02405091
What this trial is testing

Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 167
Testing effectiveness (Phase 2)Study completedNCT01733121
What this trial is testing

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 102
Large-scale testing (Phase 3)Study completedNCT01543321
What this trial is testing

Xenazine in Late Dyskinetic Syndrome With Neuroleptics

Who this might be right for
Tardive Dyskinesia
Centre Hospitalier Universitaire, Amiens 54
Post-approval studies (Phase 4)Study completedNCT05859698
What this trial is testing

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 59
Testing effectiveness (Phase 2)Study completedNCT01921270
What this trial is testing

Dysport for the Treatment of OMD

Who this might be right for
Oral DystoniaTardive Dystonia
Emory University 18
Post-approval studies (Phase 4)Study completedNCT00164242
What this trial is testing

Treatment of Tardive Dyskinesia With Galantamine

Who this might be right for
Tardive Dyskinesia
Caroff, Stanley N., M.D. 36
Early research (Phase 1)Study completedNCT05238701
What this trial is testing

A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects

Who this might be right for
Huntington DiseaseTardive Dyskinesia
Luye Pharma Group Ltd. 104
Not applicableNot Yet RecruitingNCT06218719
What this trial is testing

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Who this might be right for
Tardive Dyskinesia
Power Life Sciences Inc. 500
Post-approval studies (Phase 4)Study completedNCT00621998
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Neuroleptic-Induced Tardive Dyskinesia
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 60
Large-scale testing (Phase 3)Study completedNCT02736955
What this trial is testing

Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 161
Testing effectiveness (Phase 2)WithdrawnNCT02064010
What this trial is testing

Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

Who this might be right for
Drug-induced Tardive Dyskinesia
Synchroneuron Inc.
Next Page